BPC-157/TB-500 Blend

Two separate peptides supplied together in one vial. BPC-157 is a pentadecapeptide, C62H98N16O22 at 1419.5 g/mol, CAS 137525-51-0 (PubChem CID 9941957), sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. TB-500 is a shorter seven residue peptide, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, acetylated at the N-terminus, C38H68N10O14 at 889.0 g/mol, CAS 885340-08-9 (PubChem CID 62707662). Oasis Labs supplies the blend as a lyophilized powder at 99%+ documented purity for laboratory research use only.

Packaging, not chemistry. The blend contains the same two compounds Oasis Labs lists individually, combined in a single vial at a stated ratio rather than supplied as two separate items. It is listed in two presentations, SKU BPCTB-5-5MG and SKU BPCTB-10-10MG. Each component retains its own molecular identity, and the Certificate of Analysis documents each of them. No combined property is claimed for the blend, and published preclinical literature on each compound is specific to that compound. The blend and the single items are all supplied strictly as research reagents. No human or veterinary use is described, supported or intended.

Published preclinical literature has investigated each compound separately in in vitro and animal models. Reported work on BPC-157 concerns cell migration and angiogenesis pathways within those assay systems; reported work on TB-500 concerns actin-binding behaviour within those assay systems. Findings on one are specific to that compound. Oasis Labs supplies this material strictly as a research reagent. No human or veterinary use is described, supported or intended.

Available as SKU BPCTB-5-5MG and SKU BPCTB-10-10MG. Supplied as a vial of lyophilized powder, white to off-white in appearance, at 99%+ combined documented purity by HPLC across the two components. Component identities: BPC-157, C62H98N16O22, 1419.5 g/mol, CAS 137525-51-0, fifteen residues; and TB-500, C38H68N10O14, 889.0 g/mol, CAS 885340-08-9, seven residues with an acetylated N-terminus. The Certificate of Analysis reports a purity figure for the lot and a separate net content for each component.

Oasis Labs supplies the BPC-157 and TB-500 blend direct to researchers from the USA, with fulfilment handled in Las Vegas, Nevada. Current pricing and bulk options are shown on the product page. Every lot is third-party tested and the Certificate of Analysis is published on the site and can be read in full before ordering. The BPC-157 and TB-500 blend COA is available at myoasislabs.com/coa/bpc-157-tb-500-blend/ and the full testing methodology is documented at myoasislabs.com/coa-process/.

No. This product is sold FOR RESEARCH USE ONLY and is not for human or veterinary use, including medical, therapeutic or diagnostic applications. It is intended exclusively for in vitro laboratory research conducted by qualified professionals. It is not a drug, food, cosmetic, dietary supplement or medical device, and nothing on this page describes or recommends administration to humans or animals.